Related Articles
Successful treatment of non‑small‑cell lung cancer with afatinib and a glucocorticoid following gefitinib‑ and erlotinib‑induced interstitial lung disease: A case report
Effect of osimertinib treatment on lung adenocarcinoma with squamous cell transformation harboring the T790M mutation: A case report and literature review
A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer
Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients
Drug resistance mechanisms and progress in the treatment of EGFR‑mutated lung adenocarcinoma (Review)